Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Meta Expands AI Training With Employee Activity Tracking Tools 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
OLATHE, Kan., March 01, 2016 -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the NTrainer System® demonstrated improved transition to independent oral feeding. The improvements led to reduced use of feeding tubes and a reduction in length of stay (LOS) in the neonatal intensive care unit (NICU). Dr. Dongli Song, the principal investigator of the trial at Santa Clara Valley Medical Center in San Jose, California, received notification that the Pediatric Academic Societies (PAS) group has accepted two abstracts for poster presentation at the annual meeting.
“We are excited to have the opportunity to present our study at PAS. Achieving independent oral feeding represents an essential developmental milestone for premature infants. We need innovative therapies to improve their feeding readiness,” said Dr. Song. “I hope our presentation at this international conference will bring greater attention to this important issue.”
“This is an exciting development that will help the neonatal community better understand the developmental needs and capabilities of the premature infant,” said Michael Peck, CEO of Innara Health. “The reduced requirement for tube feeding, supported by the trial, could result in improved patient safety and reduced healthcare costs, as well as help these infants get home to their families sooner.”
The poster presentation of the trial will demonstrate objective data from 189 patients in a randomized control trial conducted at Santa Clara Valley Medical Center in San Jose, California; Children's Hospital at Montefiore-Weiler Division, Albert Einstein College of Medicine in Bronx, New York; Cook Children's Medical Center in Fort Worth, Texas; Children's Hospital at Montefiore-Wakefield Division, Albert Einstein College of Medicine in Bronx, New York; and North Central Baptist Hospital in San Antonio, Texas. The two poster sessions are scheduled to be presented at PAS in late April 2016.
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
Contact Wendy Slatery Telephone 913-742-4456 E-mail [email protected]
